Insider · CIK 0001272181
Carol Schafer
Files at INSM (INSMED Inc), KURA (Kura Oncology, Inc.), IMNM (Immunome Inc.), RPTX (Repare Therapeutics Inc.). First filing -, latest -.
Carol Schafer files SEC Form 4 as director at INSM (INSMED Inc), and also at KURA (Kura Oncology, Inc.), IMNM (Immunome Inc.), RPTX (Repare Therapeutics Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Carol Schafer has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | IMNM Immunome Inc. | AGrant or award Director Stock Option (right to buy)derivative | +9,897 | $0.00 | $0 | 9,897 | Jun 12, 2026 |
| Jun 4, 2026 | KURA Kura Oncology, Inc. | AGrant or award Option to purchase common stockderivative | +35,000 | $0.00 | $0 | 35,000 | Jun 4, 2026 |
| May 13, 2026 | INSM INSMED Inc | AGrant or award Common Stock | +3,305 | - | - | 66,622 | May 15, 2026 |
| Jan 28, 2026 | RPTX Repare Therapeutics Inc. | DDisposition to issuer Common Shares | -8,000 | - | - | 0 | Jan 28, 2026 |
| Jan 28, 2026 | RPTX Repare Therapeutics Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -37,941 | $0.00 | $0 | 0 | Jan 28, 2026 |
| Jun 10, 2025 | IMNM Immunome Inc. | AGrant or award Director Stock Option (right to buy)derivative | +18,864 | $0.00 | $0 | 18,864 | Jun 12, 2025 |
| Jun 5, 2025 | KURA Kura Oncology, Inc. | AGrant or award Option to purchase common stockderivative | +28,500 | $0.00 | $0 | 28,500 | Jun 6, 2025 |
| May 15, 2025 | INSM INSMED Inc | AGrant or award Common Stock | +5,058 | - | - | 63,317 | May 19, 2025 |
Questions about Carol Schafer
Answered from the filings on this page, as of the latest one.
Is Carol Schafer buying or selling?
Carol Schafer has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Carol Schafer's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Carol Schafer has 0.
Where does Carol Schafer file Form 4?
Carol Schafer has filed Form 4 at INSM (INSMED Inc); KURA (Kura Oncology, Inc.); IMNM (Immunome Inc.); RPTX (Repare Therapeutics Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.